Dublin, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Gene Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The crispr and cas gene market size has grown exponentially in recent years. It will grow from $3.28 billion in 2023 to $3.97 billion in 2024 at a compound annual growth rate (CAGR) of 21.3%. The CRISPR and cas gene market size is expected to see exponential growth in the next few years. It will grow to $8.37 billion in 2028 at a compound annual growth rate (CAGR) of 20.5%.
The growth observed during the historical period can be attributed to several factors, including increased consumer awareness, a shift in consumer values, the rise in celebrity endorsements, the growing popularity of veganism, and increased influence from social media platforms. North America was the largest region in the CRISPR and Cas gene market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The anticipated growth in the upcoming period can be attributed to several factors, including the global expansion of bans on certain ingredients, the rise of conscious consumerism, the emergence of new brands in the market, initiatives focused on consumer education, and the promotion of beauty inclusivity. Key trends expected in the forecast period encompass advancements in technology, product innovations, the development of a circular beauty economy, growth in the men's grooming segment, and an increased focus on social justice and ethical sourcing within the beauty industry.
The anticipated increase in focus on personalized therapy is set to drive the growth of the CRISPR and Cas gene markets in the future. Personalized therapy involves utilizing an individual's genetic profile to inform decisions regarding disease diagnosis, treatment, and prevention. CRISPR and the Cas gene, particularly Cas9, play a pivotal role in personalized medicine by enabling precise modifications to an individual's genetic material, offering potential breakthroughs in tailored therapies for genetic disorders, cancer, and various medical conditions. Thus, the growing demand for personalized therapy is expected to fuel the growth of the CRISPR and Cas gene markets.
Key players in the CRISPR and Cas gene markets are actively developing innovative products such as CRISPR-based cell-based gene therapy to enhance their product offerings and gain a competitive edge. CRISPR-based cell-based gene therapy involves utilizing CRISPR gene-editing technology to modify or correct genetic material within cells, presenting a targeted and potentially transformative approach to treating genetic disorders, diseases, and other medical conditions at the cellular level.
CASGEVY is a CRISPR/Cas9 genome-edited gene therapy indicated for managing sickle cell disease (SCD) in individuals aged 12 and above who experience recurrent vaso-occlusive crises. This first-of-its-kind therapy has the potential to offer a one-time transformative treatment for eligible sickle cell patients. Vertex is collaborating with experienced institutions to establish a network of approved treatment centers (ATCs) across the United States to administer CASGEVY to patients, requiring specific training in stem cell transplantation.
In January 2022, Bayer AG, a Germany-based pharmaceutical company, entered into a collaboration with Mammoth Biosciences to harness the natural richness in advancing the next generation of CRISPR products. This partnership aims to utilize Mammoth's CRISPR systems for developing in vivo gene-editing therapies, enhancing Bayer's emerging cell and gene therapy platform. The collaboration aligns with Mammoth Biosciences' goal of unlocking the full potential of innovative CRISPR systems. Mammoth BioSciences is a US-based biotechnology company specializing in developing CRISPR-Cas gene diagnostic tests.
The regions covered in the crispr and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the CRISPR and Cas gene market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The CRISPR and Cas gene market consists of revenues earned by entities by offering services such as gene editing, targeted disruption of genes, targeted drug development, livestock breeding, and animal model construction. The market value includes the value of related goods sold by the service provider or included within the service offering.
The CRISPR and Cas gene market also includes sales of RNA clean-up kits, phenol-free kits, t7 polymerase mix, and RNAse-free water. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
CRISPR and Cas Gene Market Competitive Landscape and Company Profiles
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc
- AstraZeneca plc.
- Danaher Corporation
- Quest Diagnostics
CRISPR and Cas Gene Market Other Major and Innovative Companies
- Lonza Group AG
- Bio-Rad Laboratories Inc.
- eGenesis
- Novartis Institutes for BioMedical Research
- Myriad Genetics Inc.
- GenScript
- Takara Bio Inc.
- 23andMe Inc.
- Merck KGaA
- Color Genomics Inc.
- Horizon Discovery Group Plc
- Beam Therapeutics Inc
- Intellia Therapeutics Inc.
- New England BioLabs
- Recursion Pharmaceuticals Inc
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 175 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value (USD) in 2024 | $3.97 Billion |
| Forecasted Market Value (USD) by 2028 | $8.37 Billion |
| Compound Annual Growth Rate | 20.5% |
| Regions Covered | Global |
Key Topics Covered:
1. Executive Summary
2. CRISPR and Cas Gene Market Characteristics
3. CRISPR and Cas Gene Market Trends and Strategies
4. CRISPR and Cas Gene Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global CRISPR and Cas Gene Market Size and Growth
5.1. Global CRISPR and Cas Gene Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global CRISPR and Cas Gene Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global CRISPR and Cas Gene Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. CRISPR and Cas Gene Market Segmentation
6.1. Global CRISPR and Cas Gene Market, Segmentation by Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Kits and Enzymes
- Libraries
- Design Tool
- Antibodies
- Other Products Types
6.2. Global CRISPR and Cas Gene Market, Segmentation by Service Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Cell Line Engineering
- gRNA Design
- Microbial Gene Editing
- DNA Synthesis
6.3. Global CRISPR and Cas Gene Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Clinical
- Financial
- Operational and Administrative
6.4. Global CRISPR and Cas Gene Market, Segmentation by End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Biotechnology and Pharmaceutical Companies
- Academics and Government Research Institutes
- Contract Research Organizations (CROs)
7. CRISPR and Cas Gene Market Regional and Country Analysis
7.1. Global CRISPR and Cas Gene Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global CRISPR and Cas Gene Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
For more information about this report visit https://www.researchandmarkets.com/r/4rms8v
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
